24th Sep 2018 14:30
LONDON (Alliance News) - Shield Therapeutics PLC on Monday said Chief Executive Carl Sterritt bought more shares in the company in a deal on Friday last week.
Sterritt pruchased 88,235 shares at 34 pence each, for a total of GBP30,000. Shield shares were trading at that price on Monday afternoon, down 2.9%.
He now holds 10.2 million Shield Therapeutics shares, 8.7% of the entire company.
Related Shares:
Shield Thera